Givaudan stock slips as bond issue and dividend expectations shape outlook
Published on 09/07/2026 at 15:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Givaudan stock (ISIN CH0010645932) was quoted at 3,218.00 CHF on SIX Swiss Exchange on September 7, 2026, down 1.0% from the prior close of 3,250.00 CHF according to market data from finanzen.ch. The intraday low stood at 3,201.00 CHF, with 295 shares changing hands by 09:28 Central European Summer Time, placing the stock among the weaker names in the Swiss Market Index at that point.
Price moves against a strong 52-week backdrop
As of September 7, 2026, Givaudan shares are trading roughly in the middle of a broad 52-week range, which has seen a high of 3,592.00 CHF on October 23, 2025 and a low of 2,566.00 CHF on March 23, 2026, based on data compiled by finanzen.ch. From the current level of 3,218.00 CHF, the stock stands 20.26% above the 52-week low, while it sits 11.62% below the 52-week high, illustrating both the recovery from the spring trough and the remaining distance to last year’s peak.
The trading volume of 295 shares reported in the morning session on September 7, 2026 suggests a relatively quiet start to the day, though the price reaction of minus 1.0% signals some profit taking after the rebound from the March 2026 lows, according to the same finanzen.ch overview. For investors, the range between 2,566.00 CHF and 3,592.00 CHF provides a clear reference frame for assessing downside risk and potential upside.
Recent bond issue and 2025 key figures support investment case
Beyond day-to-day price moves, Givaudan’s capital structure and operating performance offer important context. On August 31, 2026, the company announced the successful placement of 300 million CHF of Swiss franc bonds, strengthening its funding base and underscoring access to capital markets, as highlighted on the official investor page of Givaudan. The bond issue provides flexibility for continued investment in growth initiatives and potential portfolio developments.
Fundamentally, Givaudan closed fiscal year 2025 with Group sales of 7,472 million CHF, representing like-for-like sales growth of 5.1% compared with 2024 according to its investor fact sheet on Givaudan. Within this total, the Taste & Wellbeing segment delivered 2.4% like-for-like sales growth, while Fragrance & Beauty expanded by 7.9% on the same basis, illustrating a stronger dynamic in the fragrance activities. This segment split shows how growth is increasingly driven by beauty and fragrance applications, which can offer attractive margins.
Profitability remained solid in 2025, with EBITDA of 1,751 million CHF and an EBITDA margin of 23.4% reported by Givaudan. Net income reached 1,071 million CHF for the year, reflecting the company’s ability to convert sales growth into bottom-line earnings, and underlining the resilience of the business even in a challenging macro environment. For shareholders, the 2025 dividend stood at 72.00 CHF per share, a level that analysts now expect to edge up to 73.75 CHF in 2026 according to estimates cited by finanzen.ch, implying a year-on-year increase of 2.43% if these expectations are met.
Analyst expectations and earnings calendar
Current analyst consensus points to continued profit generation, with expectations for earnings of 117.43 CHF per share in 2026 as reported by finanzen.ch. Relative to the 2025 net income of 1,071 million CHF on Group sales of 7,472 million CHF, this anticipated 2026 earnings per share figure suggests that the market is looking for modest further progress, helped by the underlying sales growth and disciplined cost control indicated by the 23.4% EBITDA margin in 2025 on Givaudan.
The earnings calendar also provides visibility for investors planning around upcoming disclosures. According to information compiled by finanzen.ch, Givaudan is expected to release its fourth-quarter and full-year 2026 results on January 22, 2027, with fourth-quarter 2027 figures scheduled for publication on January 28, 2028. These dates mark key checkpoints where the company’s performance will be measured against the current expectations for 2026 earnings and dividend growth.
Investor events and sector positioning
Beyond formal results announcements, Givaudan maintains an active investor relations program. The company’s investor page lists a Summer Investor Conference in Zurich on August 27, 2026 and an Investor Field Trip in Naarden, Netherlands on September 29-30, 2026, designed to deepen engagement with the financial community, as shown on Givaudan. Such events typically offer more detailed insight into strategy, innovation pipelines and segment dynamics, which can inform analyst models and investor sentiment.
In the broader specialty ingredients and fragrance market, Givaudan’s positioning is supported by exposure to high-value applications such as taste and wellbeing, fragrance and beauty, and nutraceutical components. For example, an industry report on berry polyphenol extracts highlights Givaudan and its Naturex unit among key players supplying natural extracts for food, beverage and health applications, underscoring the company’s role in functional ingredients, according to Fact.MR. This mix of traditional fragrance and flavor products with more health-oriented ingredients offers diversified revenue streams and potential long-term growth.
Representative product and application focus
One representative line of business for Givaudan is its portfolio of fragrance solutions used in fine perfumes, personal care and home care products. These fragrance compositions translate consumer trends into tailored scents for global brands, often under long-term supply agreements. The strong 7.9% like-for-like sales growth in the Fragrance & Beauty segment in 2025, as reported by Givaudan, suggests that demand for these products outpaced the broader Group, reflecting both innovation and pricing power in this area. For investors, the segment’s performance is a concrete indicator of how consumer preferences and brand investments can drive revenue growth within Givaudan’s portfolio.
Stock level and investor perspective
As of the morning session on September 7, 2026, Givaudan stock is trading at 3,218.00 CHF on SIX Swiss Exchange, 1.0% below the prior close and roughly midway between its 52-week low of 2,566.00 CHF and high of 3,592.00 CHF according to finanzen.ch. With a history of robust margins, steady dividend growth from 72.00 CHF in 2025 and expectations for 73.75 CHF in 2026, and a recent 300 million CHF bond placement on August 31, 2026 noted by Givaudan, the stock offers a blend of income and defensive growth characteristics that many long-term investors in the specialty chemicals and ingredients space continue to watch closely.
Givaudan stock key data
- Company: Givaudan SA
- ISIN: CH0010645932
- Ticker: GIVN
- Trading venue: SIX Swiss Exchange
- Price (as of September 7, 2026, 09:28): 3,218.00 CHF
- Market capitalization: 29.1 billion CHF (as of September 7, 2026)
- Sector / Industry: Consumer Staples / Specialty Chemicals, Flavors and Fragrances
- Index membership: SMI (Swiss Market Index)
- Next earnings date: January 22, 2027
